ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,941, issued on Oct. 6, was assigned to SIMCERE PHARMACEUTICAL Co. LTD. (Nanjing, China) and JIANGSU SIMCERE PHARMACEUTICAL Co. LTD. (Nanjing,... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,942, issued on Oct. 6, was assigned to VERU INC. (Miami). "Methods of treating influenza and poxvirus viral infections" was invented by Mitc... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,943, issued on Oct. 6, was assigned to PELTHOS THERAPEUTICS INC. (Durham, N.C.). "Injectable formulations in a method for treating pain" was... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,944, issued on Oct. 6, was assigned to Neoculi Pty Ltd (Burwood, Australia). "Methods and compositions for treating fungal infections" was i... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,945, issued on Oct. 6, was assigned to ABAXYS THERAPEUTICS (Marbais, Belgium). "Compound for the treatment and prevention of central nervous... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,946, issued on Oct. 6, was assigned to Animal Ethics Pty Ltd (Yarra Glen, Australia). "Topical anaesthetic composition having improved vasoc... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,947, issued on Oct. 6, was assigned to LIQMEDS WORLDWIDE Ltd. (Weedon, Great Britain). "Oral liquid formulation of apixaban" was invented by... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,948, issued on Oct. 6, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Dosage forms for TYK2 inhibitors" was invented by Sherif... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,949, issued on Oct. 6, was assigned to Novartis AG (Basel, Switzerland). "Crystalline forms of a BTK inhibitor" was invented by Daniela Angs... Read More
ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,950, issued on Oct. 6, was assigned to Flex Pharma LLC (New Brighton, Minn.). "Amorphous nilotinib microparticles and uses thereof" was inve... Read More